Elanco Animal Health Incorporated
ELAN
$24.88
-$1.21-4.64%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.14B | 1.14B | 1.24B | 1.19B | 1.02B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.14B | 1.14B | 1.24B | 1.19B | 1.02B |
| Cost of Revenue | 555.00M | 530.00M | 528.00M | 509.00M | 501.00M |
| Gross Profit | 589.00M | 607.00M | 713.00M | 684.00M | 519.00M |
| SG&A Expenses | 331.00M | 351.00M | 400.00M | 341.00M | 294.00M |
| Depreciation & Amortization | 139.00M | 140.00M | 136.00M | 128.00M | 130.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.12B | 1.11B | 1.16B | 1.07B | 1.01B |
| Operating Income | 26.00M | 27.00M | 85.00M | 121.00M | 14.00M |
| Income Before Tax | -259.00M | -50.00M | 25.00M | 60.00M | -51.00M |
| Income Tax Expenses | 17.00M | -16.00M | 14.00M | -7.00M | -43.00M |
| Earnings from Continuing Operations | -276.00M | -34.00M | 11.00M | 67.00M | -8.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -276.00M | -34.00M | 11.00M | 67.00M | -8.00M |
| EBIT | 26.00M | 27.00M | 85.00M | 121.00M | 14.00M |
| EBITDA | 194.00M | 195.00M | 246.00M | 273.00M | 168.00M |
| EPS Basic | -0.56 | -0.07 | 0.02 | 0.14 | -0.02 |
| Normalized Basic EPS | -0.07 | -0.03 | 0.03 | 0.09 | -0.06 |
| EPS Diluted | -0.56 | -0.07 | 0.02 | 0.13 | -0.02 |
| Normalized Diluted EPS | -0.07 | -0.03 | 0.03 | 0.09 | -0.06 |
| Average Basic Shares Outstanding | 496.90M | 496.80M | 496.60M | 495.10M | 494.40M |
| Average Diluted Shares Outstanding | 496.90M | 496.80M | 500.10M | 499.10M | 494.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |